New procedures for a minimally invasive era: transapical beating-heart septal myectomy for hypertrophic obstructive cardiomyopathy.
This study, conducted as a prospective, single-center (Tongji Hospital in Wuhan, China), single-arm trial by a single surgeon, is the first in humans to assess the transapical beating-heart septal myectomy (TA-BSM) procedure.